Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eliem Therapeutics, Inc. | EVP, R&D AND CSO | Common Stock | 31.3K | $250K | $7.98 | Jul 22, 2024 | Direct |
Eliem Therapeutics, Inc. | EVP, R&D AND CSO | Stock Option (Right to Buy) | 10.2K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELYM | Eliem Therapeutics, Inc. | Jul 19, 2024 | 4 | -$988K | 4 | Jul 23, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Jul 17, 2024 | 2 | -$289K | 4 | Jul 19, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Jul 16, 2024 | 1 | -$357K | 4 | Jul 17, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Jul 12, 2024 | 2 | -$651K | 4 | Jul 16, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Jul 9, 2024 | 3 | -$737K | 4 | Jul 11, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Jul 5, 2024 | 1 | -$87.1K | 4 | Jul 9, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Jul 1, 2024 | 3 | -$338K | 4 | Jul 3, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Apr 5, 2024 | 2 | $3.57 | 4 | Apr 8, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Sep 20, 2023 | 4 | $13.90 | 4 | Mar 4, 2024 | EVP, R&D AND CSO |
ELYM | Eliem Therapeutics, Inc. | Mar 10, 2023 | 4 | $523 | 4 | Mar 14, 2023 | EVP, R&D and CSO |
ELYM | Eliem Therapeutics, Inc. | Oct 31, 2022 | 1 | $0 | 4 | Nov 2, 2022 | EVP, R&D and CSO |
ELYM | Eliem Therapeutics, Inc. | Jan 27, 2022 | 1 | $0 | 4 | Jan 31, 2022 | EVP, R&D and CSO |
ELYM | Eliem Therapeutics, Inc. | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | Chief Scientific Officer |